La Roche Posay - Anthelios UV Mune 400 50+ Fluide Invisible

SENSITIVE SKIN

VERY HIGH PROTECTION. VERY DURABLE. INVISIBLE.

WHAT IT IS

ANTHELIOS UVMUNE 400 INVISIBLE FLUID SPF50+: With MEXORYL400, the most effective sunscreen filter against the most harmful UV rays: ULTRA LONG UVA*. Absolute protection (UVB + UVA + ULTRA LONG UVA) against deep cell damage. Tested on sensitive, reactive and intolerant skin. Suitable for all skin types, all phototypes.

Extremely durable: to water and sand. High tolerance. It does not sting the eyes. Thin texture. With hypoallergenic aroma.

APPLICATION:

For daily use and sun exposure. Apply the sunscreen product just before exposure. Apply regularly and generously to maintain the level of protection, especially after sweating or toweling.

TEXTURE

Extremely thin. Invisible finish. Non-greasy.

Non-sticky. With La Roche-Posay thermal water.

KEY BENEFITS

For sensitive or reactive skin. Also suitable for sun-allergic skin.

It can be applied around the eyes. It does not sting the eyes. Hypoallergenic.

For more than 25 years, Anthelios has been a pioneer in major innovations: UVA filters, broad spectrum protection, textures and technologies. For all skin types, all phototypes.

THE SCIENCE BEHIND THE PRODUCT

MEXORYL400: After 10 years of research, 25 patents and more than 65 studies, we present the new exclusive UV filter. Mexoryl 400 protects against the most harmful UV rays: ULTRA LONG UVA* up to 400 nanometers.

XL-PROTECT: A patented filter technology, provides very high broad spectrum protection from UVB/UVA and helps protect against damage caused by pollution and infrared radiation.

With NETLOCK TECHNOLOGY for Ultimate protection, extremely resistant to an invisible texture.

Tested under dermatological control on sensitive and reactive skin.

Tested under ophthalmological control on sensitive eyes and eye contour.

Tested on contact lens wearers.

Allergy tested.

La Roche-Posay sun care is recommended by 60,000 dermatologists worldwide* *

Source: Research conducted in the dermocosmetics market, conducted by AplusA and other partners during the period January 2021-July 2021, involving dermatologists in 34 countries, representing over 82% of global GDP.